CHIP Clinic's goals: Research, preventive care
Investigators making strides in cancer drug discovery
CHIP clinic in the works
Not all mutations are prognosticative
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic researchers first to show sensitivity of IDH1/2 mutations to PARP inhibitor olaparib
Largest genomic assessment of MDS to date
Maciejewski honored for work in bone marrow failure syndromes
Gene mutations discovered in some patients may lead to malignancy
Cleveland Clinic researchers contradict notion that most adult myeloid neoplasms occur sporadically
Researchers suspect that mutations may be leukemogenic